Template Assembled Cyclopeptides as Multimeric System for Integrin Targeting and Endocytosis
Didier Boturyn, Jean‐Luc Coll, Élisabeth Garanger et al. · Journal of the American Chemical Society · 2004
The alpha(V)beta(3) integrin receptor plays an important role in human metastasis and tumor-induced angiogenesis. c[-RGDfV-] peptide represents a selective alpha(V)beta(3) integrin ligand that has been extensively used for research, therapy, and diagnosis of neoangiogenesis. We report here the modular synthesis and biological characterization of template assembled cyclopeptides as a multimeric system for targeting and endocytosis of cells expressing alpha(V)beta(3) integrin. c[-RGDfK-] was cleanly assembled in a multivalent mode by chemoselective oxime bond formation to a cyclodecapeptides template labeled by different reporter groups. Binding propensity to the alpha(V)beta(3) receptor and the associated good uptake property displayed by the multivalent molecules demonstrated the interest in the RAFT molecule to design new multimeric system with hitherto unreported properties. These compounds offer an interesting perspective for the reevaluation of integrins as angiogenesis regulators (Hynes, R. O. Nature Med. 2003, 9, 918-921) as well as for the design of more sophisticated systems such as molecular conjugate vectors.
Cited by 222 works. doi:10.1021/ja049926n
Authors
References
- Integrins: Versatility, modulation, and signaling in cell adhesion
- Requirement of Vascular Integrin α v β 3 for Angiogenesis
- Cancer Treatment by Targeted Drug Delivery to Tumor Vasculature in a Mouse Model
- αv Integrins as receptors for tumor targeting by circulating ligands
- Cell adhesion and motility depend on nanoscale RGD clustering
- Facile synthesis of homogeneous artificial proteins
- N -Methylated Cyclic RGD Peptides as Highly Active and Selective α V β 3 Integrin Antagonists
- Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever
- Calixarenes. 19. Syntheses procedures for p-tert-butylcalix[4]arene
- Stereoisomeric Peptide Libraries and Peptidomimetics for Designing Selective Inhibitors of the α v β 3 Integrin for a New Cancer Therapy